Determination of a catechol-O-methyltransferase inhibitor, nitecapone, in human plasma and urine by liquid chromatography.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Journal of Pharmaceutical and Biomedical Analysis

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0731-7085(91)80238-5PMID 2043724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of major metabolites of the catechol-O-methyltransferase-inhibitor nitecapone in human urine.

  1991cited by this paper
• Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors.

  1989cited by this paper
• Abstracts of the sixth International Conference on Experimental Ulcer. August 28-31, 1988, Jerusalem, Israel.

  1988cited by this paper
• Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat.

  1988cited by this paper
• Effect of dopamine-related drugs on duodenal ulcer induced by cysteamine or propionitrile: prevention and aggravation may not be mediated by gastrointestinal secretory changes in the rat.

  1987cited by this paper
• Experimental basis for a role for sulfhydryls and dopamine in ulcerogenesis: a primer for cytoprotection--organoprotection.

  1986cited by this paper
• Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine.

  1982cited by this paper
• Catechol-O-methyl transferase: pharmacological aspects and physiological role.

  1975cited by this paper

• Bioanalytical chromatographic methods for the determination of catechol-O-methyltransferase inhibitors in rodents and human samples: a review.

  2012cites this paper
• The effects of the COMT inhibitor nitecapone for one week on exercise haemodynamics and catecholamine disposition

  2004cites this paper
• Synthesis and in vitro evaluation of two progressive series of bifunctional polyhydroxybenzamide catechol-O-methyltransferase inhibitors.

  1997cites this paper
• Identification of major metabolites of the catechol-O-methyltransferase inhibitor nitecapone in the rat and dog.

  1993cites this paper
• Liquid chromatographic determination of a new catechol-O-methyltransferase inhibitor, entacapone, and its Z-isomer in human plasma and urine.

  1992cites this paper
• Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone

  1991cites this paper
• Determination of nitecapone and (13C6)nitecapone in human plasma by gas chromatography/mass spectrometry.

  1991cites this paper